Association of Programmed Death-Ligand 1 Expression with Aggressive Histological Types of Thyroid Carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Management and Research"
DOI: 10.2147/cmar.s392475
Abstract: Introduction Immunohistochemical expression of programmed death-ligand 1 (PD-L1) has become a biomarker to predict the usefulness of cancer immunotherapy using PD-1/PD-L1 blockade in a variety of advanced-stage tumours. This emerging biomarker may serve to generate… read more here.
Keywords: expression aggressive; aggressive histological; histological types; programmed death ... See more keywords